et al. Screen-detected breast cancers have a lower mitotic activity index. Br J Cancer. 2000;82:381-38410646892Google ScholarCrossref 32. Joensuu H, Lehtimäki T, Holli K. et al. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA. 2004...
et al. Screen-detected breast cancers have a lower mitotic activity index. Br J Cancer. 2000;82:381-38410646892Google ScholarCrossref 32. Joensuu H, Lehtimäki T, Holli K. et al. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA. 2004...
cancerscreening mitoticactivityindexWe know that screening for breast cancer leads to detection of smaller tumours with less lymph node metastases. Could it be possible that the decrease in mortality after screening is not only caused by this earlier stage, but also by a different mitotic activity ...
In recent decades, the risks of mammographic screening, such as false positive screening results and overdiagnosis, have been debated [1,2,3,4]. Consequently, the current breast cancer screening strategy has been questioned at the same time as more personalized approaches have been promoted [5,6...
This guideline updates the American Cancer Society breast cancer screening recommendations for women at average risk for breast cancer.
Breast Cancer Screening: Making Sense of Complex and Evolving Evidence covers broad aspects of breast cancer screening specifically focusing on current evidence, emerging evidence ... read full description Purchase book Share this bookBrowse content ...
Since mammography can be performed for both screening and diagnostic purposes, we excluded women where the index of suspicion for diagnostic tests was high, i.e. those with any breast cancer before or on April 1, 2010, any mastectomy, lumpectomy, axillary lymph nodes removal, prophylactic ovary...
第三篇:“Global guidelines for breast cancer screening: A systematic review”,于2022年1月29日收到投稿,4月9日接收。 6.文章出版费(APC) The Breast的金色开放获取出版费为2,380美元(不含税)。 文章出版费用以官网为准。 ...
Population-based screening might be associated with a higher likelihood of a (ultra)low risk tumor assessed by the 70-gene signature (MammaPrint) (ultralow defined as indexscore >0.6, no distant metastasis observed at 5 years in the original 78 patients). The aim of this study is to determi...
The cost of breast cancer screening in the Medicare population. JAMA Internal Med. Published online January 7, 2013. doi: 10.1001/jamainternmed.2013.1397. eTable 1. Elixhauser conditions included in comorbidity index eTable 2. Screening and downstream breast procedures 1. Bach PB. Limits on ...